Tumoricidal Effects of Macrophage-activating Immunotherapy in a Murine Model of Relapsed/ Refractory Multiple Myeloma

Myeloma remains a virtually incurable malignancy. The inevitable evolution of multi-drug resistant clones and widespread clonal heterogeneity limit the potential of traditional and novel therapies to eliminate minimal residual disease, a reliable harbinger of relapse. Here we show potent anti-myelom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Res
Main Authors: Jensen, Jeffrey L., Rakhmilevich, Alexander, Heninger, Erika, Broman, Aimee Teo, Hope, Chelsea, Phan, Funita, Miyamoto, Shigeki, Maroulakou, Ioanna, Callander, Natalie, Hematti, Peiman, Chesi, Marta, Bergsagel, P. Leif, Sondel, Paul, Asimakopoulos, Fotis
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527950/
https://ncbi.nlm.nih.gov/pubmed/25941352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0025-T
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados